UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of respiratory cell and molecular biology, ISSN 1044-1549, 11/2015, Volume 53, Issue 5, pp. 585 - 600
lung | matrix metalloproteinase | fibrosis | idiopathic pulmonary fibrosis | interstitial lung disease | Respiratory System | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Matrix Metalloproteinases, Secreted - metabolism | Idiopathic Pulmonary Fibrosis - genetics | Macrophages, Alveolar - pathology | Humans | Matrix Metalloproteinases, Secreted - antagonists & inhibitors | Epithelial-Mesenchymal Transition - drug effects | Epithelial-Mesenchymal Transition - genetics | Molecular Targeted Therapy | Lung - enzymology | Matrix Metalloproteinase Inhibitors - therapeutic use | Disease Models, Animal | Lung - pathology | Signal Transduction | Extracellular Matrix - drug effects | Gene Expression Regulation | Matrix Metalloproteinases, Secreted - classification | Macrophages, Alveolar - enzymology | Randomized Controlled Trials as Topic | Cell Movement - drug effects | Animals | Macrophages, Alveolar - drug effects | Lung - drug effects | Matrix Metalloproteinases, Secreted - genetics | Idiopathic Pulmonary Fibrosis - pathology | Idiopathic Pulmonary Fibrosis - enzymology | Mice | Extracellular Matrix - pathology | Idiopathic Pulmonary Fibrosis - drug therapy | Transcription factors | Pulmonary fibrosis | Pathogenesis | Rodents | Collagen | Mortality | MicroRNAs | DNA methylation | Epigenetics | Gene expression | Adapter proteins | Growth factors
Journal Article
Journal of cellular biochemistry, ISSN 0730-2312, 11/2017, Volume 118, Issue 11, pp. 3531 - 3548
MATRIX METALLOPROTEINASES | MMP INHIBITORS | CANCER BIOMARKERS | TUMOR PROGRESSION | EPITHELIAL MESENCHYMAL TRANSITION | BREAST CANCER | TUMOR MICROENVIRONMENT | TISSUE INHIBITORS OF METALLOPROTEINASES | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Tumor Microenvironment - drug effects | Breast Neoplasms - enzymology | Animals | Humans | Epithelial-Mesenchymal Transition - drug effects | Female | Neoplasm Proteins - antagonists & inhibitors | Collagenases - metabolism | Neoplasm Proteins - metabolism | Breast Neoplasms - drug therapy | Tissue Inhibitor of Metalloproteinases - metabolism | Matrix Metalloproteinase Inhibitors - therapeutic use | Proteins | Prevention | Medical research | Analysis | Stem cells | Physiological aspects | Medicine, Experimental | Development and progression | Breast cancer | Health aspects | Cancer | Tissue inhibitor of metalloproteinases | Regulators | Matrix metalloproteinases | Mesenchyme | Clinical trials | Antibodies | Matrix metalloproteinase | Promotion | Zinc | Inhibitors | Extracellular matrix | Metalloproteinase | Inhibition | Index Medicus | Prospects
Journal Article
Advanced drug delivery reviews, ISSN 0169-409X, 02/2016, Volume 97, pp. 56 - 68
Cell–matrix interactions | Angiogenesis | Extracellular matrix | Matricellular | Fibrosis | Cell-matrix interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Animals | Extracellular Matrix Proteins - therapeutic use | Humans | Drug Delivery Systems | Fibronectins | Drugs | Drug delivery systems | Health aspects | Vehicles | Index Medicus | cell-matrix interactions | fibrosis | angiogenesis | matricellular
Journal Article